Investing.com -- Kala Pharmaceuticals Inc (NASDAQ:KALA) stock dropped 6.7% Friday after the company announced the closing of its previously announced registered direct offering that raised ...

Kala Bio focuses on developing therapies for rare and severe diseases of the eye using its proprietary mesenchymal stem cell secretome platform. Its lead product candidate, KPI-012, had previously ...

ARLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative ...

KALA BIO Inc. (NASDAQ: KALA) jumped 37.87% to $0.88 in after-hours trading on Tuesday. Check out the current price of KALA stock here. According to Benzinga Pro data, the stock closed the regular ...

A Chaska woman was killed in a crash late Sunday night in Scott County, according to an incident report from the Minnesota State Patrol. Authorities say 46-year-old Kala Karlene Henry was driving a ...

SHAKOPEE, Minn. — A woman is dead after a crash in Shakopee late Sunday night. The Minnesota State Patrol reported that 46-year-old Kala Karlene Henry of Chaska was headed south on Highway 169 near ...

JawaPos.com - Cibubur dikenal sebagai kawasan yang unik—bukan hanya karena lokasinya yang berada tepat di persimpangan empat wilayah besar Jakarta Timur, Depok, Bogor, dan Bekasi, tetapi juga karena ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Arlington biotech has been ...

Kala Bio said it laid off most of its employees after receiving notice that its lender, Oxford Finance, intends to foreclose on all of its remaining assets. The move follows the biotech company's ...

Shares of KALA BIO KALA have nosedived 88.3% in a month after the company announced the failure of a mid-stage study evaluating its only clinical pipeline candidate, KPI-012, for the treatment of ...

Shares of Kala Bio plummeted Monday after the company said a study of its treatment for Persistent Corneal Epithelial Defect, an eye defect, missed its primary endpoints and it would stop development ...

Sept 29 (Reuters) - Kala Bio (KALA.O), opens new tab will stop developing its experimental treatment for a type of eye condition after it failed to meet the main goal in a mid-stage study, sending the ...